Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06349837
Status:
RECRUITING
Last Update Posted:
2024-04-05
First Post:
2024-03-31
Brief Title:
Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors
Sponsor:
Sichuan University
Organization:
Sichuan University
Organization Data
Organization:
Sichuan University
Class:
OTHER
Study ID:
ECLIPSE-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sichuan University
Lead Sponsor Class:
OTHER
Responsible Party:
You Lu
Responsible Party Title:
Chair of Department of Thoracic Cancer
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Sichuan University
Old Name:
None
Old Organization:
None